Iovance Biotherapeutics, Inc.
IOVA
$3.89
-$0.15-3.71%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/12/2026
-
MarketBeat
3/17/2026
-
Simply Wall St
Iovance Biotherapeutics (IOVA, $4.04) Stochastic Oscillator left the oversold zone on March 16, 2026
3/17/2026
-
Tickeron - Technical Analysis
3/16/2026
-
MarketBeat
3/14/2026
-
Yahoo! Finance: News
3/14/2026
-
Tickeron - Stocks
3/14/2026
-
Insider Monkey
3/13/2026
-
Tickeron - Stocks
3/12/2026
-
Tickeron - Stocks
3/11/2026
-
MarketBeat
3/11/2026
-
Seeking Alpha: Transcripts
3/11/2026
-
SeekingAlpha
Iovance Biotherapeutics (IOVA) Is Up 42.7% After Positive Lifileucel Sarcoma Data And New Trial Plan
3/10/2026
-
Simply Wall St
3/10/2026
-
Insider Monkey
3/9/2026
-
Simply Wall St
3/8/2026
-
MarketBeat
3/8/2026
-
Ticker Report
3/8/2026
-
Simply Wall St
3/8/2026
-
Insider Monkey
3/8/2026
-
Insider Monkey
3/7/2026
-
MarketBeat
Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine
3/7/2026
-
Insider Monkey
3/7/2026
-
Insider Monkey
3/7/2026
-
Insider Monkey
6/29/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 24, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 260 7120
Address
825 Industrial Road
San Carlos, CA 94070
San Carlos, CA 94070
Country
Year Founded
Business Description
Sector
Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of...
more